Commentary: Comment on “Comparative analysis of blood routine, C-reactive protein, and biochemical markers in children with Mycoplasma pneumoniae pneumonia and its coinfections”

The study confirmed Mycoplasma pneumoniae pneumonia (MPP) using immunoglobulin (Ig)-M (titer ≥1:160) and RNA isothermal amplification. However, it lacks key details needed to ensure diagnostic accuracy. First, the study did not report the agreement between serological and molecular tests, which is a critical omission given their inconsistent performance in children. The United States (U.S.) Centers for Disease Control and Prevention (CDC) explicitly notes that serological testing for MP lacks specificity and often requires paired acute and convalescent sera to minimize false negatives, as single-sample IgM detection may miss early infections due to delayed seroconversion 2 . Second, single MP-IgM testing shows poor sensitivity and specificity in acute pediatric MPP. In a study of 144 confirmed cases, sensitivity was 85.5%, but specificity was only 25.6%, indicating it is unreliable as a standalone diagnostic too 3 . Another study demonstrated MP-IgM sensitivity as low as 61.2%, meaning around 38.8% of children with true MP infection would be falsely negative 4 .Without details on the timing of testing relative to symptom onset or the agreement between tests, the validity of the "MPP-confirmed" cohort is questionable.The conclusion that Haemophilus influenzae coinfection worsens disease severity lacks support from standardized evaluations. A meta-analysis indicates that severity assessment in pediatric pneumonia is hindered by inconsistent definitions and lack of consensus on core indicators 5 . Most studies rely on non-standardized outcomes, such as length of hospital stay, which do not reflect the disease's biological characteristics.Moreover, this review emphasizes that effective severity assessment requires integrating objective clinical indicators, such as oxygenation status and respiratory rate, instead of relying solely on symptom duration. The British Thoracic Society (BTS) guideline for pediatric community-acquired pneumonia (CAP) delineates severity-based criteria to inform clinical decision-making; however, Ambroggio et al. 6 reported in their study that this guideline exhibits suboptimal sensitivity, specifically with regard to the evaluation of need for hospitalization and the determination of patient disposition. Additionally, hospital length of stay correlates weakly with true disease severity because it is influenced by non-clinical factors such as parental requests and bed availability. Therefore, objective indicators like oxygen saturation and the need for respiratory support are essential for robust severity stratification. Omitting validated scales and objective metrics weakens the evidence supporting a causal relationship between coinfection and disease severity.We propose the following suggestions to further enhance the scientific rigor and clinical value of the study: